Even after COVID-19 crisis, social isolation continues Even after most coronavirus measures have been discontinued, some people are still living in social isolation to avoid COVID-19 exposure.
Tailor-made information will help immigrants make decisions on taking part in screening programmes Immigrants are relatively less likely to take part in preventive screening programmes, such as cancer screening. This is partly due to the language barrier and a lack of knowledge, according to a doctoral thesis by Nora Hamdiui.
Can healthy gut microbes protect us against antibiotic-resistant bacteria? It is largely assumed within the scientific community that a healthy intestinal microbiome can provide resistance against the settling, growth and multiplication of antibiotic-resistant bacteria.
People who work at night are more likely to get infected with coronavirus People who occasionally or regularly work at night are 37% more likely to test positive for coronavirus than people who only work during the daytime. This is one of the conclusions of a study by the RIVM (Netherlands).
Enthusiasm and challenges when adopting a broad view of health More and more parties in the Netherlands, including healthcare and welfare organisations, local authorities and municipal and communal healthcare services, are using so-called ‘broad health concept’.
At least 87% of people over 65 vaccinated at least once: high turnout, few regional differences Four months after the launch of the vaccination campaign, at least 87% of people over 65 in the Netherlands have been vaccinated against COVID-19 at least once.
Quality assessment of SARS-CoV-2 antigen test diagnostics: good performance at public test sites in the Netherlands In their role as WHO reference laboratories, RIVM and Erasmus UMC conducted a study on the quality of SARS-CoV-2 antigen diagnostics in the Netherlands.
Long-term symptoms more common after Lyme disease More than a quarter of people with Lyme disease continue to have long-term symptoms that lead to limitations in daily life even after treatment.
RIVM updates guidelines for AstraZeneca interval As of 21 May, RIVM updated the guidelines for the interval between two doses of the AstraZeneca vaccine. The interval can now be between 6 and 14 weeks.
Social well-being is improving, compliance with coronavirus measures remains important With the recent easing of the coronavirus measures, social contact and well-being are improving again. Compliance with most measures remains stable for now (such as getting tested by the GGD and avoiding crowds) or is decreasing very gradually.